A recent finding reported that a gain-of-function mutant p53, found in 75% of pancreatic adenocarcinoma, highly drived tumor metastasis via uridine 5′-diphosphatase in the ER [25]. The gene discussed is TP53; the disease is pancreatic adenocarcinoma.